ACCOUNTS - Final Accounts

ACCOUNTS - Final Accounts

NIMROD LIFE SCIENCES LIMITED - Company Information

Print Friendly Version

Caseware UK (AP4) 2020.0.247 2020.0.247 2020-09-302020-09-302019-10-0100The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsefalsetrue 02543120 2019-10-01 2020-09-30 02543120 2018-10-01 2019-09-30 02543120 2020-09-30 02543120 2019-09-30 02543120 c:Director1 2019-10-01 2020-09-30 02543120 c:Director2 2019-10-01 2020-09-30 02543120 d:CurrentFinancialInstruments 2020-09-30 02543120 d:CurrentFinancialInstruments 2019-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2020-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2019-09-30 02543120 d:ShareCapital 2020-09-30 02543120 d:ShareCapital 2019-09-30 02543120 d:SharePremium 2020-09-30 02543120 d:SharePremium 2019-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2020-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2019-09-30 02543120 c:OrdinaryShareClass1 2019-10-01 2020-09-30 02543120 c:OrdinaryShareClass1 2020-09-30 02543120 c:OrdinaryShareClass1 2019-09-30 02543120 c:FRS102 2019-10-01 2020-09-30 02543120 c:AuditExempt-NoAccountantsReport 2019-10-01 2020-09-30 02543120 c:FullAccounts 2019-10-01 2020-09-30 02543120 c:PrivateLimitedCompanyLtd 2019-10-01 2020-09-30 02543120 6 2019-10-01 2020-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02543120









NIMROD LIFE SCIENCES LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2020
 
NIMROD LIFE SCIENCES LIMITED
REGISTERED NUMBER: 02543120

BALANCE SHEET
AS AT 30 SEPTEMBER 2020

2020
2019
Note
£
£

FIXED ASSETS
  

Investments
 4 
243,418
243,418

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
10,434
10,120

Cash at bank
  
890,693
892,295

  
901,127
902,415

Creditors: amounts falling due within one year
 6 
(1,644)
(1,596)

NET CURRENT ASSETS
  
 
 
899,483
 
 
900,819

  

NET ASSETS
  
1,142,901
1,144,237


CAPITAL AND RESERVES
  

Called up share capital 
 7 
8
8

Share premium account
  
109,409
109,409

Profit and loss account
  
1,033,484
1,034,820

  
1,142,901
1,144,237


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Mr M J M Rawe
Mr S J Lawrence
Director
Director
Date:  26 March 202126 March 2021

The notes on pages 2 to 4 form part of these financial statements.

Page 1
 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

1.


GENERAL INFORMATION

Nimrod Life Sciences Limited limited by shares and incorporated in England and Wales. Its registered office is Unit 1, Priors Hall, Widdington, Saffron Walden, Essex, CB11 3SB.  The company's functional and presentational currency is GBP and the figures in these financial statements are rounded to the nearest pound.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

The ongoing global health crisis caused by COVID-19 has had a significant impact on all businesses and economies around the globe. The directors have assessed the potential impact of Coronavirus on the Company and its assets with the information available and do not consider that it will lead to any impairment of the carrying amount of reported assets.  The directors have also concluded that the impact of the pandemic is unlikely to mean that the Company will not be able to continue as a going concern.

 
2.3

VALUATION OF INVESTMENTS

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.4

DEBTORS

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

CREDITORS

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 2
 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

2.ACCOUNTING POLICIES (CONTINUED)

 
2.7

PENSIONS

The company contributes to the personal pension plans of the directors.
The contributions are recognised as an expense in the Profit and Loss Account when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of these plans are held separately from the Company in independently administered funds.

 
2.8

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


3.


EMPLOYEES

The Company has no employees other than the directors, who received no contributions into their personal  pension plans (2019 - £50,000).



4.


FIXED ASSET INVESTMENTS





Investments in subsidiary companies

£



COST


At 1 October 2019
243,418



At 30 September 2020
243,418





5.


DEBTORS

2020
2019
£
£


Amounts owed by group undertakings
10,434
10,120


Page 3
 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

6.


CREDITORS: Amounts falling due within one year

2020
2019
£
£

Accruals and deferred income
1,644
1,596



7.


SHARE CAPITAL

2020
2019
£
£
Allotted, called up and fully paid 



8 (2019 - 8) Ordinary shares of £1.00 each
8
8

 
Page 4